Effectiveness of an Interactive Digital Learning Platform (Dental Trauma Guide) on Knowledge and Clinical Decision-Making Skills in Management of Traumatic Dental Injuries Among a Group of Dental Interns

November 4, 2026 updated by: Amaal Ahmed Ibrahem, Future University in Egypt

Effectiveness of an Interactive Digital Learning Platform (Dental Trauma Guide) on Knowledge and Clinical Decision-Making Skills in Management of Traumatic Dental Injuries Among a Group of Dental Interns A Randomized Controlled Trial

Statement of the problem:

Traumatic dental injuries (TDIs) are among the most common dental emergencies encountered in clinical practice and represent a significant burden in both primary and secondary healthcare settings. These injuries frequently affect children and young adults and may lead to long-term functional, aesthetic, and psychological consequences if not managed appropriately. The global burden of TDIs is considerable, with epidemiological studies indicating that a large proportion of individuals experience dental trauma during their lifetime.

Crown fractures are the most frequently reported type of injury, whereas luxation injuries and alveolar bone fractures present greater diagnostic and management challenges.

TDIs are particularly prevalent among school-aged populations due to increased exposure to physical activities, sports injuries, and accidental falls. In addition, delayed or inappropriate management may result in pulpal necrosis, root resorption, or tooth loss, increasing treatment complexity and cost.

Successful management of TDIs requires immediate and accurate diagnosis, correct classification, and evidence-based treatment planning. However, undergraduate dental students often demonstrate limited clinical confidence and inadequate decision-making skills due to insufficient exposure to trauma cases.

Previous studies have identified gaps in knowledge and clinical competence among dental students and interns and general practitioners in managing TDIs. This highlights the need for improved educational strategies.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Not yet recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

Two groups will be included

Participants will be randomly assigned into two of either equal groups:

• Control group will receive traditional teaching material on management of different TDIs.

• Intervention group will use the DTG during clinical training to support diagnosis and treatment planning.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
144

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

20 years to 30 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Dental interns enrolled in the Faculty of Oral and Dental Medicine, Future University in Egypt.

Description

Inclusion Criteria:

  • Inclusion Criteria:

    • Dental interns enrolled in the Faculty of Oral and Dental medicine, Future University in Egypt.
    • Students willing to participate and provide an informed consent.
    • Students with basic familiarity with digital learning tools.

Exclusion Criteria:

  • Exclusion Criteria:

    • Students who have previously received formal training using the Dental Trauma Guide (DTG).
    • Students with prior advanced clinical experience in the management of traumatic dental injuries.
    • Students who refuse or are unwilling to provide written informed consent.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: OTHER
  • Time Perspectives: PROSPECTIVE

Cohorts and Interventions

Group / Cohort

Group / Cohort

A group or subgroup of participants in an observational study that is assessed for biomedical or health outcomes.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Control group will receive traditional teaching material on management of different TDIs.
Other: This study is a randomized controlled trial with parallel groups with 1:1 allocation ratio.

compare the effectiveness of the DTG learning platform and traditional teaching methods in improving knowledge for management of traumatic dental injuries among a group of dental interns.
Intervention group will use the DTG during clinical training to support diagnosis and treatment plan
Other: This study is a randomized controlled trial with parallel groups with 1:1 allocation ratio.

compare the effectiveness of the DTG learning platform and traditional teaching methods in improving knowledge for management of traumatic dental injuries among a group of dental interns.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Time Frame
To compare the effectiveness of the DTG learning platform and traditional teaching methods in improving knowledge for management of traumatic dental injuries among a group of dental interns.
Time Frame: 6 months
6 months
To evaluate and compare knowledge for management traumatic dental injuries between the DTG learning platform and traditional teaching methods using Multiple Choice Questions (MCQs). • To assess and compare clinical reasoning skills in management of traum
Time Frame: 6 months
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Future University in Egypt

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
December 1, 2026

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
August 1, 2027

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
September 1, 2027

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
November 4, 2026

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
November 4, 2026

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
November 9, 2026

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
November 9, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
November 4, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
November 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • (Dental Trauma Guide)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings